drug
aripiprazole lauroxil ER
Marketedupdated 2mo agoby Alkermes US Holdings Inc
Approvedcommunity read0 votes
indications
investigational
Schizophrenia
all catalysts(0)
nothing on the calendar yet
Trials studying aripiprazole lauroxil ER
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 24, 2030
~3.9 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (71)
- Apr 6, 2039method-of-use (U-543)US 11273158
- Apr 6, 2039method-of-use (U-543)US 11273158
- Apr 6, 2039method-of-use (U-543)US 11273158
- Apr 6, 2039method-of-use (U-543)US 11273158
- Apr 6, 2039method-of-use (U-543)US 11273158
- Apr 6, 2039method-of-use (U-543)US 12251381
- Apr 6, 2039method-of-use (U-543)US 12251381
- Apr 6, 2039method-of-use (U-543)US 12251381
- Apr 6, 2039method-of-use (U-543)US 12251381
- Apr 6, 2039method-of-use (U-543)US 12251381
- Sep 8, 2035formulationUS 10016415
- Aug 17, 2035formulationUS 10688091
- Aug 17, 2035method-of-use (U-543)US 10849894
- Aug 17, 2035formulationUS 11154552
- Mar 19, 2035method-of-use (U-2402)US 10238651
- Mar 19, 2035method-of-use (U-2402)US 10238651
- Mar 19, 2035method-of-use (U-2402)US 10238651
- Mar 19, 2035method-of-use (U-2402)US 10238651
- Mar 19, 2035method-of-use (U-2402)US 10813928
- Mar 19, 2035method-of-use (U-2983)US 10813928
- Mar 19, 2035method-of-use (U-2983)US 10813928
- Mar 19, 2035method-of-use (U-2983)US 10813928
- Mar 19, 2035method-of-use (U-2402)US 11406632
- Mar 19, 2035method-of-use (U-2402)US 11406632
- Mar 19, 2035method-of-use (U-2402)US 11406632
- Mar 19, 2035method-of-use (U-2402)US 11406632
- Mar 19, 2035method-of-use (U-2402)US 9452131
- Mar 19, 2035method-of-use (U-2402)US 9452131
- Mar 19, 2035method-of-use (U-2402)US 9452131
- Mar 19, 2035method-of-use (U-2402)US 9452131
- Mar 19, 2035formulationUS 9526726
- Mar 19, 2035formulationUS 9526726
- Oct 24, 2033formulationUS 11097006
- Oct 24, 2033formulationUS 11097006
- Oct 24, 2033formulationUS 11097006
- Oct 24, 2033formulationUS 11097006
- Oct 24, 2033formulationUS 11969469
- Oct 24, 2033formulationUS 11969469
- Oct 24, 2033formulationUS 11969469
- Oct 24, 2033formulationUS 11969469
- Oct 24, 2033formulationUS 9193685
- Oct 24, 2033formulationUS 9193685
- Oct 24, 2033formulationUS 9193685
- Oct 24, 2033formulationUS 9193685
- Sep 19, 2033formulationUS 12311027
- Sep 19, 2033formulationUS 12311027
- Sep 19, 2033formulationUS 12311027
- Sep 19, 2033formulationUS 12311027
- Nov 7, 2032formulationUS 9034867
- Nov 7, 2032formulationUS 9034867
- Nov 7, 2032formulationUS 9034867
- Nov 7, 2032formulationUS 9034867
- Mar 19, 2032method-of-use (U-543)US 10226458
- Mar 19, 2032method-of-use (U-543)US 10226458
- Mar 19, 2032method-of-use (U-543)US 10226458
- Mar 19, 2032method-of-use (U-543)US 10226458
- Oct 26, 2030compositionUS 84315764.3y
- Oct 26, 2030compositionUS 84315764.3y
- Oct 26, 2030compositionUS 84315764.3y
- Oct 26, 2030compositionUS 84315764.3y
- Oct 26, 2030compositionUS 84315764.3y
- Jun 24, 2030compositionUS 101129033.9y
- Jun 24, 2030compositionUS 101129033.9y
- Jun 24, 2030compositionUS 101129033.9y
- Jun 24, 2030compositionUS 101129033.9y
- Jun 24, 2030compositionUS 101129033.9y
- Jun 24, 2030method-of-use (U-543)US 87962763.9y
- Jun 24, 2030method-of-use (U-543)US 87962763.9y
- Jun 24, 2030method-of-use (U-543)US 87962763.9y
- Jun 24, 2030method-of-use (U-543)US 87962763.9y
- Jun 24, 2030method-of-use (U-543)US 87962763.9y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 7m ago
Found something off?
comments(0)
5-min edit window · permanent after that